Daniel Addison, MD
@md_addison
Director, UTSW CV Translational Research & Endowed Chair; Associate Director in UTSWCCC; Chair, AHA Cardiac Imaging Committe; Physician-Scientist @UTSWMedCenter
Excited for my next chapter: Honored to join @UTSWMedCenter as an Associate Director in @utswcancer, Translational Research Director & Endowed Chair in CV division. dmagazine.com/healthcare-bus… Grateful to my #OSUWexMed colleagues for last 8 years. Proud of #cardioonc success.
Excited to finally see our #NIH R01 funded! I am hopeful we can leverage #AI to help many #BreastCancer patients avoid #cardiotoxicity. #cardioonc #blackmeninmedicine #NCI
#cardioonc #medicine #blackmeninmedicine
Congrats to Daniel Addison, M.D., cardiologist and Associate Professor of Internal Medicine at #UTSW, who will be inducted into @the_asci on April 25. As clinical-translational researcher, Dr. Addison focuses on cardio-oncology and advanced cardiac imaging. #AcademicMedicine
🚨 St Francis Heart Center, NY #CardioOnc Journal Club 📖 with @OPCILive . @md_addison (Ohio State University) joins us to discuss CV events associated with Bispecific antibody therapy for cancer 🦠. Watch episode: opci.live/opci-lives/car… @StFrancis_LI @CHS_LI
Recap #ACC25 #AF in cancer patients by @md_addison ✅ Driven by inflammation, therapies & CV risks ⚠️ Worsens survival 🩺 Novel therapies linked to AF: ▪️ BTK inhibitors (i.e ibrutinib) ▪️ ICI, CAR-T, BiTE therapies 🔎 #whyCMR predicts outcomes in ibrutinib-associated AF
Day 2️⃣ highlights from ACC's #CardioOnc: ☑️ Significant reductions in cardiac dose w/ improved radiation therapy ☑️ TKI cardiomyopathy may be reversible w/ GDMT & 🔎 monitoring ☑️ Breast cancer survivors are at an ↗️ long-term CV risk ☑️ And more! #ACCCardioOnc
This statement examines how artificial intelligence (AI) can be utilized to enhance risk prediction models in cardio-oncology, advancing the field toward precision medicine. ✍🏼 @rohan_khera @AartiAsnaniMD @md_addison @Avasbind @rimajamal99 @DrTochiOkwuosa
Honored to be selected to join this prestigious physician-scientist society @the_asci. Culmination of some of the hard work over the last 8 years. Grateful to all those involved in the journey. #cardioonc #blackmeninmedicine #cancerresearch #ASCI
Congrats to Daniel Addison, MD on his election as a member of the American Society for Clinical Investigation! @OSUWexMed @OhioStateMed @md_addison @the_asci Read more here: bit.ly/4aaBQeP
#cardionc
I ran into these friends randomly while wandering the halls of #AHA24 and had a great convo which ended with this nifty photo (pose courtesy of Jane) at the #AHA sign. This is why I love going to conferences 😎@AHAScience @AHAMeetings @Joseph_C_Wu @jennkwanMDPhD @md_addison
Who’s excited for #AHA2024 ? Get ready to join us for a great #cardioonc session @ 9:45 ! S401D
Grateful for a Fall dinner for our #cardioonc research team last week. Excited for their positive impact on #cancer patient lives.
Excited for a nice score: 8% Cardiotoxicity Risk Prediction in Breast Cancer Patients via multi-modal AI system MPI R01 w/ Weidan Cao, Dakuo Wang and @AIMedLab With @DrGattiMays Happy to also see a mentee, Dr. Coa, reach PI status! #cardioonc #ArtificialInteligence #Cancer
Cardiac considerations with Emerging Cancer Cellular Therapies: ashpublications.org/bloodadvances/… Thanks @BloodAdvances for publishing this work. Excellent work by @MalakMunirMD @ASayedMD @NEpperla #cardioonc #cancer #leukemia #lymphoma
Cardiotoxicity is a significant concern with novel T-cell therapies 🫀🎯 Our recent review in @BloodAdvances explores: -Reported rates 📊 -Risk factors ⚠️ -Management strategies 🩺 -Unanswered questions 🔍 Full paper 👉 10.1182/bloodadvances.2024013849 #CardioOnc #MedTwitter
Agreed!! #cardioonc
Great end to an outstanding #GCOS2024 Thank you @BlaesAnneMD Dr. Suma Konety @ICOSociety !
COMING UP - @md_addison, @dr_manisty, and @CardiacCTGuy discuss different #imaging techiques in #cardioonc THEN - @vgzmd , @cezar_ciliescu , @Dr_Iakobishvili , @mayocvonc discuss cardioac interventions during and after cancer treatment #GCOS2024 #cardionc
#cardioonc #blackmeninmedicine
A+ Grand rounds by @md_addison for @UCSFCardiology! Outstanding overview of imaging & #CardioOnc! Many great contributions 2 our understanding of BTK inhibitors & #CardioTox! Looking forward 2 many great collaborations!
Atrial Fibrillation Burden and Clinical Outcomes in Patients with BTK Inhibitor Cardiotoxicity: nature.com/articles/s4137… Thanks @LeukemiaJnl for publishing this work. #CardioOnc #CLL #BTK #AtrialFibrillation #leukemia @GambrilAlan @ICOSociety @datsunian
#cardioonc
Congrats to Daniel Addison, MD and team on their OSU President's Research Excellence Accelerator Award! @md_addison @OhioStateMed @OSUWexMed @OhioStateERIK Learn more here: bit.ly/3WG2d7l
#cardioonc #leukemia #atrialfibrillation
Comparison of AF prevalence and cardiovascular 🫀 outcomes in patients undergoing and allo- and auto-HSCT 🧬 doi.org/10.1038/s41598… Super grateful to @md_addison for his mentorship! @ZainAsadEP @SanamMGhazi @Cooper_25maine @AlmaHabibMD
Excited for tomorrow’s #cardioonc and #amyloid hybrid CME symposium! FREE (final) registration below ⬇️ #kittlesonrules #cardiac
Join us for the 4th Annual OSU #CardioOnc CME hybrid conference this Saturday June 1st: Full agenda & FREE registration: ccme.osu.edu/continuing-med. @salimhayek @CardioOnc_MR_CT @MKlttlesonMD @DSadlerMD @AdamPotterMDPhD @CampbellMDPhD @avirupguha #CardioTwitter #CardioEd #cancer